TG Therapeutics, Inc.TGTXNASDAQ
LOADING
|||
Year-over-year revenue growth rate
| Period | Value |
|---|---|
| Q3 2025 | 14.57% |
| Q2 2025 | 16.79% |
| Q1 2025 | 11.71% |
| Q4 2024 | 28.98% |
| Q3 2024 | 14.17% |
| Q2 2024 | 15.74% |
| Q1 2024 | 44.35% |
| Q4 2023 | -73.48% |
| Q3 2023 | 931.57% |
| Q2 2023 | 106.00% |
| Q1 2023 | 9653.75% |
| Q4 2022 | -14.89% |
| Q3 2022 | -84.18% |
| Q2 2022 | -70.54% |
| Q1 2022 | -13.14% |
| Q4 2021 | 14.33% |
| Q3 2021 | 31.39% |
| Q2 2021 | 94.83% |
| Q1 2021 | 1986.84% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -0.25% |
| Q4 2017 | -0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | -0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | -0.00% |